PofoliaShared via Pofolia

Indian Journal of Gastroenterology· 2026Q2· Review

Outcomes of Clostridium difficile infection in liver transplant patients: A systematic review and meta-analysis

Muhammad Shahzil, Fariha N. Hasan, Ammad Javaid Chaudhary, Syeda Hafsa Qadri et al.

Short summary

Clostridioides difficile infection (CDI) significantly increases mortality (OR 1.87), hospital stay (7 days longer), and pre-operative MELD scores (2.77 higher) in liver transplant (LT) recipients, despite initial analyses showing no significant mortality difference.

AI-generated from the title and abstract; the full text is not read.

Key points

  • Liver transplant recipients with Clostridioides difficile infection (CDI) had a 1.87-fold increased mortality risk (sensitivity analysis).
  • CDI was associated with a 7-day longer hospital stay in liver transplant recipients (sensitivity analysis).
  • CDI cases had significantly higher pre-operative MELD scores (mean difference 2.77), indicating greater baseline disease severity.
  • Proton pump inhibitor (PPI) use was significantly associated with an increased risk of CDI (sensitivity analysis).

AI-generated from the title and abstract; the full text is not read.

Abstract

Abstract Background Clostridioides difficile infection (CDI) is a significant healthcare-associated complication, especially for liver transplant (LT) recipients who are at increased risk due to their immuno-suppressed status and antibiotic use. This systematic review and meta-analysis aimed at elucidating the outcomes of CDI in LT recipients. Methods We adhered to PRISMA guidelines and searched databases including CENTRAL, PubMed, Embase and Scopus until December 2024. Studies included LT recipients with and without CDI. Outcomes were pooled using meta-analytic techniques with risk ratios (RR) for dichotomous data and mean differences for continuous data. Results Among 10 included studies (1,216,500 LT recipients; 3.2% with CDI), the primary pooled analysis showed no significant difference in mortality (OR, 1.34; 95% CI, 0.38–4.72; I 2 = 100%). Sensitivity analyses excluding influential studies showed higher mortality in LT recipients with CDI (OR, 1.87; 95% CI, 1.45–2.41; I 2 = 43%). Length of stay was longer among LT recipients with CDI (mean difference, 6.00 days; 95% CI, 2.83–9.17; I 2 = 100%), with sensitivity analysis showing a mean difference of seven days after exclusion of one study ( I 2 = 0%). Elevated model for end-stage liver disease (MELD) scores were significantly higher in CDI cases (mean difference, 2.77; 95% CI, 1.34–4.20), indicating higher disease severity at baseline. Proton pump inhibitor (PPI) use was not significant in the primary pooled analysis (OR, 2.18; 95% CI, 0.29–16.27; I 2 = 69%) but was significant after sensitivity analysis excluding one study (OR, 5.87; 95% CI, 2.65–13.03; I 2 = 0%). Conclusion In addition to a significant association between PPI use and increased risk of CDI, CDI significantly affects mortality, duration of hospital stays and pre-operative MELD scores in LT recipients, underscoring its impact on post-operative outcomes.

The authors' abstract, as published at the source. Indian Journal of Gastroenterology, 2026 · DOI ↗

TakeawaysPremium
Ask the paperFree account

Continue with a free account

Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.

Continue free on the web

Sign in with Google or Apple; no card needed. You come back to this paper.

On your phone:

Field: Infectious Diseases

Infectious DiseasesMedicine